Jeremy Graff
Fortune : 35 248 $ au 31/08/2026
Fortune : 35 248 $ au 31/08/2026
Dr. Jeremy R.
Graff is a President & Chief Development Officer at Allarity Therapeutics, Inc. and a Chairman at IN8bio, Inc. He is on the Board of Directors at Wood Hudson Cancer Research Laboratory, Inc. Dr. Graff was previously employed as a Chief Scientific Officer by IMV, Inc., a Chief Development Officer & Senior VP-Research by HiberCell, Inc., a President & Chief Scientific Officer by Biothera Pharmaceuticals, Inc. (Delaware), and a President & Chief Scientific Officer by Biothera, Inc. He received his undergraduate degree from Thomas More University and a doctorate degree from the University of Kentucky.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/04/2026 | 24 881 ( 0,16% ) | 35 082 $ | 31/08/2026 | |
| 09/05/2026 | 151 ( 0% ) | 166 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| IN8BIO, INC. | Président | 28/02/2026 |
| ALLARITY THERAPEUTICS, INC. | President | 03/10/2024 |
Wood Hudson Cancer Research Laboratory, Inc.
Wood Hudson Cancer Research Laboratory, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that provides scientific research services for cancer causes, diagnosis, treatment and prevention | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| IMV INC. | Directeur Technique/Scientifique/R&D | 01/01/2024 |
Hibercell, Inc.
Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company, which develops treatments to prevent cancer relapse and metastasis | Directeur Technique/Scientifique/R&D | 01/03/2021 |
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops natural gluco polysaccharide that engages and directs natural innate immune systems | President | 01/06/2020 |
Biothera Pharmaceuticals, Inc. (Delaware)
Biothera Pharmaceuticals, Inc. (Delaware) Medical/Nursing ServicesHealth Services Develops cancer immunotherapy | President | 01/06/2020 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops natural gluco polysaccharide that engages and directs natural innate immune systems | Commercial Services |
Thomas More University
Thomas More University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Kentucky
University of Kentucky Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IMV, Inc.
IMV, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Biothera Pharmaceuticals, Inc. (Delaware)
Biothera Pharmaceuticals, Inc. (Delaware) Medical/Nursing ServicesHealth Services Develops cancer immunotherapy | Health Services |
IN8bio, Inc.
IN8bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on delivering a novel off-the-shelf product for the treatment of cancer | Health Technology |
Hibercell, Inc.
Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company, which develops treatments to prevent cancer relapse and metastasis | Commercial Services |
Allarity Therapeutics, Inc.
Allarity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics | Health Technology |
Wood Hudson Cancer Research Laboratory, Inc.
Wood Hudson Cancer Research Laboratory, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that provides scientific research services for cancer causes, diagnosis, treatment and prevention | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national